Autologous chondrocyte implantation with a Reveille cartilage processor for articular cartilage injury: A case report

2Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Autologous chondrocyte implantation (ACI) is an important operative option when repairing cartilage defects of the knee. This report introduces a new product development with one-stage ACI using a Reveille Cartilage Processor (Reveille CP) as well as the assessment of MRI and clinical results at a 1-year follow-up. The report compared cases between a 42-year-old female who underwent ACI surgery using Reveille CP and a 51-year old female who received treatment with two-stage ACI of tissue-engineered cartilage-like tissue (J-TEC Autologous Chondrocyte Cultured Cartilage [JACC]). One year after JACC, magnetic resonance imaging (MRI) showed signal intensity area in the grafted area, while patients with Reveille CP showed greater thickness than the surrounding healthy cartilage. The Lysholm, pain and QOL scores of Knee Injury and Osteoarthritis Outcome (KOOS) at one 1 year after surgery with Reveille CP were higher than JACC.

Cite

CITATION STYLE

APA

Igarashi, T., Kaneko, T., Yoshizawa, S., Takada, K., Matsu-Ura, Y. U., Ikegami, H., & Musha, Y. (2020). Autologous chondrocyte implantation with a Reveille cartilage processor for articular cartilage injury: A case report. Journal of Surgical Case Reports, 2020(4), 1–7. https://doi.org/10.1093/JSCR/RJAA074

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free